⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for precancerous conditions

Every month we try and update this database with for precancerous conditions cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2NCT01837693
Precancerous Co...
Neoplasms
Experimental: i...
25 Years - 59 YearsAzienda Unità Sanitaria Locale Reggio Emilia
Chemoprevention of Oral Premalignant LesionsNCT00036283
Precancerous Co...
Celecoxib
18 Years - Pfizer
Chemoprevention of Oral Premalignant LesionsNCT00036283
Precancerous Co...
Celecoxib
18 Years - Pfizer
Helicobacter Pylori Eradication to Prevent Gastric CancerNCT01133951
Helicobacter In...
Stomach Neoplas...
OAC triple ther...
Placebo
30 Years - 59 YearsSecond Military Medical University
Follow-up Modalities of Low Grade Precancerous Bronchial LesionsNCT00213603
Precancerous Co...
Thoracic Neopla...
18 Years - 80 YearsUniversity Hospital, Rouen
Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former SmokersNCT03347838
Bronchial Dyspl...
Tobacco Smoking
History of Non-...
History of Head...
Nivolumab
18 Years - 80 YearsUniversity of Colorado, Denver
Collection of Blood, Bone Marrow, Tumor or Tissue SamplesNCT00043615
Neoplasms
Precancerous Co...
18 Years - National Institutes of Health Clinical Center (CC)
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)NCT03285490
Actinic Keratos...
KX2-391 Ointmen...
Placebo
18 Years - Almirall, S.A.
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisNCT06001385
Acute Lymphobla...
Acute Myeloid L...
Acute Leukemia
Myelodysplastic...
Chronic Myeloid...
Chronic Lymphoc...
Myeloproliferat...
Lymphoma
Chronic Myelomo...
Pro-Lymphocytic...
Myelofibrosis
Busulfan
Fludarabine
PBSC Hematopoie...
Post-Transplant...
Mesna
Tacrolimus
Mycophenolate M...
Patient Reporte...
Melphalan
Total-body irra...
Cyclophosphamid...
18 Years - Center for International Blood and Marrow Transplant Research
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)NCT03285490
Actinic Keratos...
KX2-391 Ointmen...
Placebo
18 Years - Almirall, S.A.
Photographic Evidence of Oral Precancerous Lesions in Current Tobacco and Areca Nut Users Improves Their Quit RatesNCT05215860
Precancerous Co...
Tobacco and are...
visual exposure...
- All India Institute of Medical Sciences, New Delhi
Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic KeratosisNCT02844777
Actinic Keratos...
Placebo
5% VDA-1102
10% VDA-1102
18 Years - Vidac Pharma
Detection of Early Gastric Cancers Using Confocal Laser EndomicroscopyNCT00851305
Stomach Neoplas...
Precancerous Co...
Endomicroscope ...
Gastroscopes (P...
45 Years - 80 YearsShandong University
Microwave Treatment for Actinic KeratosisNCT05636800
Keratosis, Acti...
Swift System
18 Years - 85 YearsBlackwell Device Consulting
Sintilimab to Prevent High-risk Oral Premalignant Lesions CancerizationNCT04065737
Oral Cavity Can...
Mouth Neoplasm
Precancerous Co...
Sintilimab
18 Years - Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Oral Epithelial Dysplasia Informational Needs QuestionnaireNCT04153266
Oral Epithelial...
Precancerous Co...
Precancerous Le...
Oral Lichen Pla...
Oral Leukoplaki...
Oral Leukoplaki...
Oral Leukoplaki...
Oral Leukoplaki...
Oral Erythropla...
Chronic Hyperpl...
Oral Submucous ...
Oral Submucosal...
Oral Disease
Dental Diseases
Dysplasia
Information See...
Patient Prefere...
Information Nee...
Health Behavior
Quality of Life
Preference, Pat...
Patient Satisfa...
Patient Engagem...
Patient Partici...
No intervention...
18 Years - University College, London
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or ScalpNCT03285477
Actinic Keratos...
Placebo
KX2-391 Ointmen...
18 Years - Almirall, S.A.
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideNCT04904588
Acute Lymphobla...
Acute Myelogeno...
Mixed Phenotype...
Acute Leukemia
Myelodysplastic...
Chronic Myeloge...
Chronic Lymphoc...
Lymphoma
Busulfan
Busulfan
Fludarabine
Total-body irra...
Cyclophosphamid...
Melphalan
PBSC Hematopoie...
Bone Marrow Hem...
Post-transplant...
Mesna
Tacrolimus
Mycophenolate M...
Patient-Reporte...
1 Year - Center for International Blood and Marrow Transplant Research
Phase I/II Study of Chemoprevention With EGFR and COX-2 InhibitorNCT00314262
Precancerous Co...
Erlotinib & Cel...
18 Years - 65 YearsEmory University
Identification of a Plasma Proteomic Signature for Lung CancerNCT01752101
Precancerous Co...
Carcinoma
40 Years - Integrated Diagnostics
Identification of a Plasma Proteomic Signature for Lung CancerNCT01752101
Precancerous Co...
Carcinoma
40 Years - Integrated Diagnostics
Natural History of Oro-pharyngeal Cancer PrecursorsNCT00179361
Precancerous Co...
Leukoplakia
Erythroplasia
Oral Papillomas
21 Years - Albert Einstein College of Medicine
Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former SmokersNCT03347838
Bronchial Dyspl...
Tobacco Smoking
History of Non-...
History of Head...
Nivolumab
18 Years - 80 YearsUniversity of Colorado, Denver
Follow-up Modalities of Low Grade Precancerous Bronchial LesionsNCT00213603
Precancerous Co...
Thoracic Neopla...
18 Years - 80 YearsUniversity Hospital, Rouen
Phase I/II Study of Chemoprevention With EGFR and COX-2 InhibitorNCT00314262
Precancerous Co...
Erlotinib & Cel...
18 Years - 65 YearsEmory University
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: